Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified
Conditions
Interventions
Intervention1: No intervention: As this is an observational study, there is no intervention being given for study purpose. However the regular treatment received by the patients will be recorded in th
Sponsors
Cipla
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients admitted with a diagnosis of acute exacerbation of COPD or who are in stable state without any exacerbations in the last 3 months as defined by GOLD criteria 2019. 2. Age above 18 years of either gender. 3. Patient residing in India for the next one year and agreeing for follow-up as per protocol. 4. Patients willing to give written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who are being transferred to other hospitals for treatment. 2. Patients with diseases such as end stage renal disease, cardiogenic shock, liver failureor any other serious unrelated diseases that could limit the life expectancy to less than 90 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Acute Exacerbations of COPD-Time to first exacerbation after hospitalization due to index event, number of exacerbations, number of unscheduled and emergency department visits for COPD, number of hospitalizations for COPD, and number of ICU admissions for COPD during the study period. Timepoint: 0, 1, 6 and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Modified Medical Research Council scale (mMRC), Modified Borg Dyspnoea Scale, EQ-5D-5L questionnaire, Body mass index, obstructive, dyspnoea and exacerbations (BODEx), Dyspnoea, obstruction, smoking and exacerbations (DOSE), Age, dyspnoea and obstruction (ADO), COPD Assessment Test (CAT) and 6-minute walk test (6MWT) during the study period. 2. Mortality during the study period. Timepoint: 0, 12 months | — |
Countries
India
Contacts
Public ContactDr Melvin George
SRM Medical College Hospital and Research Center
Outcome results
None listed